ArticleBreast cancer research : BCR2026

Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.

Alastair A E Saunders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.